Stephen Schultz | VP, IR |
Justin Gover | Chief Executive Officer |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | Chief Financial Officer |
Julian Gangolli | President, North America |
Phil Nadeau | Cowen & Company |
Jeffrey Lin | Leerink Partners |
Tazeen Ahmad | Bank of America Merrill Lynch |
Salveen Richter | Goldman Sachs |
Greetings and welcome to the GW Pharmaceuticals Fourth Quarter and Year-End 2017 results conference call. At this time all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder this conference is being recorded. I’d now like to turn the conference over to Stephen Schultz, Vice President of Investor Relations.